Stocks News

LAST PRICE
363.1600
TODAY'S CHANGE (%)
Trending Up5.9700 (1.6714%)

Bid / Lots
360.0000/ 2
Ask / Lots
368.0000/ 1
Open / Previous Close
357.8500 / 357.1900
Day Range
Low 357.6100
High 368.4050
52 Week Range
Low 226.4400
High 417.1400
Volume
1,547,700
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Oct 28, 2024
- DJ HCA Healthcare Is Maintained at Buy by TD Cowen, from 12:15PM ET on Monday Oct 28, 2024 by Dow Jones
  12:15PM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 28, 2024 12:15 ET (16:15 GMT)
- DJ HCA Healthcare Is Maintained at Overweight by Keybanc, from 9:12AM ET on Monday Oct 28, 2024 by Dow Jones
  9:12AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 28, 2024 09:12 ET (13:12 GMT)
- DJ HCA Healthcare Is Maintained at Outperform by Oppenheimer, from 9:02AM ET on Monday Oct 28, 2024 by Dow Jones
  9:02AM ET on Monday Oct 28, 2024 by Dow Jones
  Companies Mentioned: HCA
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/HCA/analyst-ratings
  
  (END) Dow Jones Newswires
  
  October 28, 2024 09:02 ET (13:02 GMT)
- TD Cowen Adjusts HCA Healthcare's Price Target to $440 From $450, Keeps Buy Rating, from 8:06AM ET on Monday Oct 28, 2024 by MT Newswires
  8:06AM ET on Monday Oct 28, 2024 by MT Newswires
  Companies Mentioned: HCA
  08:06 AM EDT, 10/28/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $316 to $460, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...
- KeyBanc Adjusts HCA Healthcare's Price Target to $420 From $475, Keeps Overweight Rating, from 8:05AM ET on Monday Oct 28, 2024 by MT Newswires
  8:05AM ET on Monday Oct 28, 2024 by MT Newswires
  Companies Mentioned: HCA
  08:05 AM EDT, 10/28/2024 (MT Newswires) -- HCA Healthcare (HCA) has an average rating of outperform and price targets ranging from $316 to $460, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research...

Today
- BMO Capital Raises Ventas Price Target to $72 From $70, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: VTR
- BMO Capital Raises Welltower Price Target to $148 From $140, from 6 hours ago by MT Newswires
  6 hours ago by MT Newswires
  Companies Mentioned: WELL
- Evercore ISI Adjusts Price Target on Ventas to $72 From $70, Maintains Outperform Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: VTR
- Evercore ISI Adjusts Price Target on Welltower to $125 From $114, Maintains In Line Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: WELL
- Wedbush Raises Welltower Price Target to $135 From $120, Maintains Neutral Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: WELL
- Wedbush Adjusts Ventas Price Target to $75 From $71, Maintains Outperform Rating, from 7 hours ago by MT Newswires
  7 hours ago by MT Newswires
  Companies Mentioned: VTR
- Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience, from 7 hours ago by Dow Jones
  7 hours ago by Dow Jones
  Companies Mentioned: LH
Oct 31, 2024
- Ventas Insider Sold Shares Worth $10,295,043, According to a Recent SEC Filing, from 5:06PM ET on Thursday Oct 31, 2024 by MT Newswires
  5:06PM ET on Thursday Oct 31, 2024 by MT Newswires
  Companies Mentioned: VTR
Oct 30, 2024
- Ventas Q3 Normalized FFO, Revenue Increase; 2024 Outlook Updated, from 4:53PM ET on Wednesday Oct 30, 2024 by MT Newswires
  4:53PM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: VTR
- -- Earnings Flash (VTR) VENTAS Reports Q3 Revenue $1.24B, from 4:12PM ET on Wednesday Oct 30, 2024 by MT Newswires
  4:12PM ET on Wednesday Oct 30, 2024 by MT Newswires
  Companies Mentioned: VTR

HCA Healthcare Inc
NYSE:HCAUnited States

Search Criteria

Oct 28, 2024

DJ HCA Healthcare Is Maintained at Buy by TD Cowen, from 12:15PM ET on Monday Oct 28, 2024 by Dow Jones

DJ HCA Healthcare Is Maintained at Overweight by Keybanc, from 9:12AM ET on Monday Oct 28, 2024 by Dow Jones

DJ HCA Healthcare Is Maintained at Outperform by Oppenheimer, from 9:02AM ET on Monday Oct 28, 2024 by Dow Jones

TD Cowen Adjusts HCA Healthcare's Price Target to $440 From $450, Keeps Buy Rating, from 8:06AM ET on Monday Oct 28, 2024 by MT Newswires

KeyBanc Adjusts HCA Healthcare's Price Target to $420 From $475, Keeps Overweight Rating, from 8:05AM ET on Monday Oct 28, 2024 by MT Newswires

Peers Headlines

Today

BMO Capital Raises Ventas Price Target to $72 From $70, from 6 hours ago by MT Newswires

BMO Capital Raises Welltower Price Target to $148 From $140, from 6 hours ago by MT Newswires

Evercore ISI Adjusts Price Target on Ventas to $72 From $70, Maintains Outperform Rating, from 7 hours ago by MT Newswires

Evercore ISI Adjusts Price Target on Welltower to $125 From $114, Maintains In Line Rating, from 7 hours ago by MT Newswires

Wedbush Raises Welltower Price Target to $135 From $120, Maintains Neutral Rating, from 7 hours ago by MT Newswires

Wedbush Adjusts Ventas Price Target to $75 From $71, Maintains Outperform Rating, from 7 hours ago by MT Newswires

Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience, from 7 hours ago by Dow Jones

Oct 31, 2024

Ventas Insider Sold Shares Worth $10,295,043, According to a Recent SEC Filing, from 5:06PM ET on Thursday Oct 31, 2024 by MT Newswires

Oct 30, 2024

Ventas Q3 Normalized FFO, Revenue Increase; 2024 Outlook Updated, from 4:53PM ET on Wednesday Oct 30, 2024 by MT Newswires

-- Earnings Flash (VTR) VENTAS Reports Q3 Revenue $1.24B, from 4:12PM ET on Wednesday Oct 30, 2024 by MT Newswires